Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT04143724 |
| Consolidated Lead Sponsor | Bristol Myers Squibb |
| Therapeutic Condition Cohort | Rare Genetic, Women's Health, and Other |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 99 participants (ESTIMATED) |
| Registered Start Date | 2019-11-07 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Shenzhen Second People's Hospital | Shenzhen, China | Open Hospital Dossier -> |
| West China Hospital,Sichuan University | Chengdu, China | Open Hospital Dossier -> |
| Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University | Guangzhou, China | Open Hospital Dossier -> |
| The first affiliated hospital of Guangxi Medical University | Nanning, China | Open Hospital Dossier -> |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for Bristol Myers Squibb across sibling Meru public-data platforms.
Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.